新型减毒活流感疫苗M2SR可保护小鼠和雪貂抵抗高致病性禽流感
研究评估了M2缺陷单复制(M2SR)流感疫苗对H5N1高致病性禽流感的保护作用。小鼠经鼻接种含H5N1或H1N1血凝素和神经氨酸酶的M2SR病毒后,所有M2SR H5N1接种小鼠在致死性攻击中存活,而重组H5 HA接种小鼠仅40%存活、未接种对照全部死亡。M2SR H5N1和H1N1均保护雪貂抵抗致死性攻击,初免-加强方案保护最佳。
要点
- M2SR H5N1接种小鼠全部存活致死性H5N1攻击,重组H5 HA组仅40%存活,未接种对照全部死亡。
- M2SR H5N1提供无菌免疫,部分M2SR H1N1接种小鼠肺内检出低水平病毒。
- M2SR H5N1和H1N1均保护雪貂抵抗致死性H5N1攻击,初免-加强方案保护最佳。
核心结论
- 同源H5N1 M2SR和异源H1N1 M2SR均能提供对高致病性H5N1流感病毒的有效保护,证明M2SR平台的交叉保护特性。
研究设计与样本
- 研究为小鼠和雪貂的动物实验,小鼠经鼻接种含A/Vietnam/1203/2004(H5N1)或A/California/07/2009(H1N1)HA和NA的M2SR病毒。
主要发现
- 所有M2SR接种小鼠在致死性A/Vietnam/1203/2004(H5N1)攻击后存活,重组H5 HA接种小鼠40%存活,未接种对照全部死亡。
- M2SR H5N1提供无菌免疫,部分M2SR H1N1接种小鼠肺内检出低水平病毒,而重组H5 HA接种小鼠和未接种对照出现全身感染。
- M2SR H5N1诱导针对H5 HA的强血清和黏膜抗体反应(IgG和IgA类),血凝抑制(HAI)滴度高;M2SR H1N1未检测到针对H5N1病毒的HAI活性。
- M2SR H5N1和H1N1均保护雪貂抵抗A/Vietnam/1203/2004致死性攻击,初免-加强方案保护最佳,攻击后呼吸道和脑内未检出病毒。
- 雪貂中仅M2SR H5N1诱导针对攻击病毒的HAI抗体,M2SR H1N1在未诱导HAI抗体的情况下提供保护。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The emergence of highly pathogenic avian influenza H5N1 viruses has heightened global concern about the threat posed by pandemic influenza. To address the need for a highly effective universal influenza vaccine, we developed a novel M2-deficient single replication (M2SR) influenza vaccine virus and previously reported that it provided strong heterosubtypic protection against seasonal influenza viruses in mice. In the current study, we assessed M2SR induced protection against H5N1 influenza in mice and ferrets. Mice were intranasally inoculated with M2SR viruses containing the HA and NA from A/Vietnam/1203/2004 (M2SR H5N1) or A/California/07/2009 (M2SR H1N1). All M2SR vaccinated mice survived lethal challenge with influenza A/Vietnam/1203/2004 (H5N1), whereas 40% of mice vaccinated with recombinant H5 HA and none of the naïve controls survived. M2SR H5N1 provided sterile immunity, whereas low levels of virus were detected in the lungs of some M2SR H1N1 vaccinated mice. In contrast, recombinant H5 HA vaccinated mice and naïve controls showed systemic infection. M2SR H5N1 induced strong serum and mucosal antibody responses (IgG and IgA classes) against H5 HA, with high hemagglutination inhibition (HAI) titers. In contrast, while M2SR H1N1 elicited cross-reactive antibodies recognizing the H5 HA2 stalk region or the neuraminidase, no HAI activity against H5N1 virus was detected after M2SR H1N1 immunization. Both M2SR H5N1 and H1N1 also protected ferrets against lethal challenge with A/Vietnam/1203/2004. A prime-boost regimen provided optimal protection with no virus detected in the respiratory tract or brain after challenge. As in the mouse model, only the M2SR H5N1 vaccine induced HAI antibodies against the challenge virus in ferrets, while the M2SR H1N1 was able to provide protection without the induction of HAI antibodies. In summary, effective protection against highly pathogenic H5N1 influenza virus was provided by both homologous H5N1 M2SR and heterologous H1N1 M2SR demonstrating the cross-protective attributes of the M2SR platform.
引用
- Hatta Y, Boltz D, Sarawar S, et al. M2SR, a novel live influenza vaccine, protects mice and ferrets against highly pathogenic avian influenza. Vaccine. 2017. PMID: 28668565. doi:10.1016/j.vaccine.2017.06.039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。